This year, we spoke to dozens of health plan pharmacy executives to ask how they assess a drug’s “value” when reimbursing for drugs or choosing which drugs to put on their formularies. Traditionally, plans evaluate drugs following a strict rubric of safety, efficacy, and unit cost. They often curate internal expertise and make decisions independently within the plan, then notify providers about drug coverage preferences.